Cargando…

Rapid Antigen Test LumiraDx(TM) vs. Real Time Polymerase Chain Reaction for the Diagnosis of SARS-CoV-2 Infection: A Retrospective Cohort Study

Background: Real time reverse transcription polymerase chain reaction (real time RT-PCR) testing is the gold standard for the diagnosis of SARS-CoV-2 infections. However, to expand the testing capacity, new SARS-CoV-2 rapid antigen tests (Ag-RDTs) have been implemented. Ag-RDTs are more rapid, but l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cattelan, Anna Maria, Sasset, Lolita, Zabeo, Federico, Ferrari, Anna, Rossi, Lucia, Mazzitelli, Maria, Cocchio, Silvia, Baldo, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997977/ https://www.ncbi.nlm.nih.gov/pubmed/35409513 http://dx.doi.org/10.3390/ijerph19073826

Ejemplares similares

Performance Evaluation of the Quantitative Point-of-Care LumiraDx d-Dimer Test
por: Ellis, Jayne E., et al.
Publicado: (2021)

Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19
por: Gresh, Jared, et al.
Publicado: (2021)

Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic Point-of-Care Setting Compared With an Established Laboratory Reference Method
por: Tait, Robert Campbell, et al.
Publicado: (2019)

Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children
por: Drain, Paul, et al.
Publicado: (2021)

Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
por: Krüger, Lisa J., et al.
Publicado: (2021)

Evaluation of the analytical sensitivity of ACON and LumiraDx SARS-CoV-2 rapid antigen tests using samples with presumed Omicron variant
por: Karon, Brad S., et al.
Publicado: (2023)

LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms
por: Ellis, Jayne E., et al.
Publicado: (2022)

Extraction-Free Detection of SARS-CoV-2 Viral RNA Using LumiraDx’s RNA Star Complete Assay from Clinical Nasal Swabs Stored in a Novel Collection and Transport Medium
por: Daum, Luke T., et al.
Publicado: (2023)

Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy: A retrospective analysis
por: Mazzitelli, Maria, et al.
Publicado: (2021)

Viro-Immunological, Clinical Outcomes and Costs of Switching to BIC/TAF/FTC in a Cohort of People Living with HIV: A 48-Week Prospective Analysis
por: Mazzitelli, Maria, et al.
Publicado: (2022)

An Integrated Strategy for the Prevention of SARS-CoV-2 Infection in Healthcare Workers: A Prospective Observational Study
por: Cattelan, Anna Maria, et al.
Publicado: (2020)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment?
por: Ferrari, Anna, et al.
Publicado: (2021)

Factors Associated with Severe COVID-19 and Post-Acute COVID-19 Syndrome in a Cohort of People Living with HIV on Antiretroviral Treatment and with Undetectable HIV RNA
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Clinical characteristics and laboratory biomarkers changes in COVID-19 patients requiring or not intensive or sub-intensive care: a comparative study
por: Cattelan, Anna Maria, et al.
Publicado: (2020)

Changing patterns and clinical outcomes of hospitalized patients with COVID-19 severe pneumonia treated with remdesivir according to vaccination status: results from a real-world retrospective study
por: Mengato, Daniele, et al.
Publicado: (2023)

Correction to: Changing patterns and clinical outcomes of hospitalized patients with COVID‑19 severe pneumonia treated with remdesivir according to vaccination status: results from a real‑world retrospective study
por: Mengato, Daniele, et al.
Publicado: (2023)

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus
por: Petrara, Maria Raffaella, et al.
Publicado: (2017)

Predictors of immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma: a case report
por: Cattelan, Anna Maria, et al.
Publicado: (2016)

Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted, Retrospective Cohort Study during the First Two Years of the COVID-19 Pandemic
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Usefulness of the Lumiradx™ SARS-COV-2 antigen test in nursing home()
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022)

Circulating miRNA‐375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS patients
por: Piano, Maria Assunta, et al.
Publicado: (2018)

“Would You Get Vaccinated against COVID-19?” The Picture Emerging from a Study on the Prevalence of SARS-CoV-2 Infection in the General Population of the Veneto Region
por: Cocchio, Silvia, et al.
Publicado: (2022)

COVID-19 Vaccination Limits Systemic Danger Signals in SARS-CoV-2 Infected Patients
por: Angioni, Roberta, et al.
Publicado: (2022)

Prevalence of Asymptomatic SARS-CoV-2 Infection in the General Population of the Veneto Region: Results of a Screening Campaign with Third-Generation Rapid Antigen Tests in the Pre-Vaccine Era
por: Cocchio, Silvia, et al.
Publicado: (2021)

The Effectiveness of a Diverse COVID-19 Vaccine Portfolio and Its Impact on the Persistence of Positivity and Length of Hospital Stays: The Veneto Region’s Experience
por: Cocchio, Silvia, et al.
Publicado: (2022)

DX centers
por: Munoz Merino, Elias
Publicado: (1994)

Cats vs. Dogs: The Efficacy of Feliway Friends(TM) and Adaptil(TM) Products in Multispecies Homes
por: Prior, Miriam Rebecca, et al.
Publicado: (2020)

COVID-19 Vaccine Effectiveness against Omicron Variant among Underage Subjects: The Veneto Region’s Experience
por: Cocchio, Silvia, et al.
Publicado: (2022)

Differences in Immunological Evasion of the Delta (B.1.617.2) and Omicron (B.1.1.529) SARS-CoV-2 Variants: A Retrospective Study on the Veneto Region’s Population
por: Cocchio, Silvia, et al.
Publicado: (2022)

Comparison of Simoa(TM) and Ella(TM) to assess serum neurofilament‐light chain in multiple sclerosis
por: Gauthier, Audrey, et al.
Publicado: (2021)

SARS-CoV-2/COVID-19 Vaccines: The Promises and the Challenges Ahead
por: Baldo, Vincenzo, et al.
Publicado: (2021)

Raman Spectroscopy vs Quantitative Polymerase Chain Reaction In Early Stage Huanglongbing Diagnostics
por: Sanchez, Lee, et al.
Publicado: (2020)

Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant Staphylococcus aureus: A Retrospective Single-Centre Experience
por: Mazzitelli, Maria, et al.
Publicado: (2022)

Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
por: Bai, Francesca, et al.
Publicado: (2023)

POLYMERASE CHAIN REACTION
por: Wages, J.M.
Publicado: (2005)

Relationship between dynamics of Epstein-Barr virus and immune activation in HIV-1 infected subjects in the HAART era
por: Cattelan, AM, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dveuiobrfl5uj2cdrrhc6rdmr5